Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- CheckyesterdayChange DetectedThe 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now loads a 403 Forbidden error page, blocking access to the study record. The visible content is replaced by a site-wide error message and footer, indicating an access restriction rather than a study data update.SummaryDifference18%

- Check22 days agoChange DetectedThe page revision label updated from v3.6.6 to v3.7.0, indicating a new build of the site’s page template. This change does not modify the study details or presented information.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata rather than substantive content changes.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now documents Revision: v3.6.5, replacing the previous v3.6.4, indicating a minor platform update.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page shows a CMS revision update from v3.6.3 to v3.6.4. This reflects a backend software update or patch rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.